Collectively, these findings indicate that snake venom exerts potent antiangiogenic effects by inhibiting endothelial cell vessel formation, suppressing VEGF expression, and reducing neovascularization in tumor models, suggesting its promise as an antiangiogenic agent for breast cancer therapy. This evidence concerns the gene VEGFA and breast carcinoma.